Discontinued OTC asthma med may make comeback

Share this article:

OTC inhaler Primatene Mist officially left the building in August 2013, just over two years after it was banned because the prescription-free asthma inhaler's chlorofluorocarbons violated environmental regulations.

Regulatory Focus reports that the last of the inhalers was officially off the market this summer, but that a Federal Register notice indicates the FDA's Pulmonary-Allergy Drugs Advisory Committee is set to consider an OTC replacement Feb. 25. The new Primatene Mist is currently operating under the name Primatene HFA.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Imbruvica lassoes CLL indication

The FDA slapped a Breakthrough Therapy label on the CLL indication pursuit in February.

FDA asks social media "how'm I doin?"

The FDA's Center for Drug Evaluation and Research's Office of Communications wants a system that will help assess its messaging reach across the interwebs and its many forums.

Reckitt Benckiser wants out of pharma

The company plans to spin off its pharmaceutical unit.